You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Pediatric Forum
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Informatics/ Internet in Medicine
 •Informatics, Other
 •Quality of Care, Other
 •Drug Therapy
 •Alert me on articles by topic

Primum Non Nocere

Arch Pediatr Adolesc Med. 2006;160:1185.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Kim et al1 demonstrated that in the practice of pediatric oncology, computerized physician order entry (CPOE) reduced improper dosing, missing cumulative doses, and incomplete nursing checklists. In contrast to these benefits, however, CPOE also resulted in a 5-fold increase in "not matching medication orders to treatment plans." Although little detail was provided on the nature of these medication order/treatment plan "mismatches," it implies that chemotherapy ordered through CPOE deviated more often from intended protocol therapy as compared with paper-ordered chemotherapy. While CPOE ostensibly led to more precise chemotherapy dosing, it increased the risk of that chemotherapy being the wrong chemotherapy.

Increasing the risk of protocol deviation in pediatric oncology has both individual patient and nationwide/study ramifications. For the individual patient, receiving protocol therapy in an unintended way has the potential to cause harm either by overtreament or undertreatment. For patients having data submitted for national study purposes, variability in protocol . . . [Full Text of this Article]

AUTHOR INFORMATION

David Dickens, MD; Dianne Sinsabaugh, RPh; Brenda Winger, PharmD


RELATED LETTER

Primum Non Nocere—Reply
George R. Kim, Allen R. Chen, Robert J. Arceci, and Christoph U. Lehmann
Arch Pediatr Adolesc Med. 2006;160(11):1185-1186.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Error Reduction in Pediatric Chemotherapy: Computerized Order Entry and Failure Modes and Effects Analysis
George R. Kim, Allen R. Chen, Robert J. Arceci, Sandra H. Mitchell, K. Michelle Kokoszka, Denise Daniel, and Christoph U. Lehmann
Arch Pediatr Adolesc Med. 2006;160(5):495-498.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.